Funding Rounds
Medlumics

Medlumics Series B (2017, $37M)

Medlumics

Manufacturer of medical devices for the treatment of supra-ventricular tachycardias.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $37.30M

Investors